Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer
Clinical trial NCT02044354 · COMPLETED
Trial details
- NCT number
- NCT02044354
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-22
- Primary completion
- 2017-04-13
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.